{
  "id": "d75644fc2109fa88",
  "title": "XTL Biopharmaceuticals Acquires 85 % of NeuroNOS , Entering the Massive Autism Market with Nobel Prize - Winning Scientific Leadership",
  "description": "20260113T150000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/13/tmt-newswire/globenewswire/xtl-biopharmaceuticals-acquires-85-of-neuronos-entering-the-massive-autism-market-with-nobel-prize-winning-scientific-leadership/2258173",
  "published_at": "20260113T150000Z",
  "fetched_at": "2026-01-14T00:24:05.619157+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/13/tmt-newswire/globenewswire/xtl-biopharmaceuticals-acquires-85-of-neuronos-entering-the-massive-autism-market-with-nobel-prize-winning-scientific-leadership/2258173",
    "url_mobile": "https://www.manilatimes.net/2026/01/13/tmt-newswire/globenewswire/xtl-biopharmaceuticals-acquires-85-of-neuronos-entering-the-massive-autism-market-with-nobel-prize-winning-scientific-leadership/2258173/amp",
    "title": "XTL Biopharmaceuticals Acquires 85 % of NeuroNOS , Entering the Massive Autism Market with Nobel Prize - Winning Scientific Leadership",
    "seendate": "20260113T150000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/13/898198.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}